Can gastritis symptoms be evaluated in clinical trials? An overview of treatment of gastritis, nonulcer dyspepsia and Campylobacter-associated gastritis
- PMID: 2677123
- DOI: 10.1097/00004836-198910000-00003
Can gastritis symptoms be evaluated in clinical trials? An overview of treatment of gastritis, nonulcer dyspepsia and Campylobacter-associated gastritis
Abstract
We carried out a review of the literature on Campylobacter pylori-associated gastritis and nonulcer dyspepsia (NUD) to determine whether or not symptoms related to these conditions can be measured reliably and whether or not any study to date has shown that treatment alters symptoms. Search strategies consisted of online Medline searching, a forward search of three articles using the Science Citation Index, a manual search of five gastroenterological journals, and a fully recursive search of cited references. Inclusion and quality criteria were applied to all retrieved studies. Nine of 23 studies did not fulfill the inclusion criteria. Of the 14 studies analyzed, two measured symptoms reliably. Neither showed a therapeutic benefit on symptoms. The difficulties encountered in conducting such studies and the methods of recording symptoms reliably are discussed. We conclude that to date, no treatment is of proven benefit in the relief of symptoms associated with C. pylori gastritis and NUD.
Similar articles
-
Indications for treatment of Helicobacter pylori infection: a systematic overview.CMAJ. 1994 Jan 15;150(2):189-98. CMAJ. 1994. PMID: 8287341 Free PMC article. Review.
-
Treatment failure of norfloxacin against Campylobacter pylori and chronic gastritis in patients with nonulcerative dyspepsia.Antimicrob Agents Chemother. 1989 Feb;33(2):256-7. doi: 10.1128/AAC.33.2.256. Antimicrob Agents Chemother. 1989. PMID: 2719469 Free PMC article.
-
Bismuth subsalicylate suppression of Helicobacter pylori in nonulcer dyspepsia: a double-blind placebo-controlled trial.Dig Dis Sci. 1993 Sep;38(9):1674-80. doi: 10.1007/BF01303177. Dig Dis Sci. 1993. PMID: 8359080 Clinical Trial.
-
[Functional upper abdominal pain in Campylobacter-associated gastritis: does the patient profit from bismuth therapy?].Z Gastroenterol. 1989 Nov;27(11):701-2. Z Gastroenterol. 1989. PMID: 2694657 Clinical Trial. German. No abstract available.
-
Nonulcer dyspepsia: association with chronic Helicobacter pylori infection-related gastritis?J Clin Gastroenterol. 1995;21 Suppl 1:S140-5. J Clin Gastroenterol. 1995. PMID: 8775007 Review.
Cited by
-
Eradication of Helicobacter pylori and long-term outcome of functional dyspepsia. A clinical endoscopic study.Dig Dis Sci. 1996 Aug;41(8):1589-94. doi: 10.1007/BF02087905. Dig Dis Sci. 1996. PMID: 8769284 Clinical Trial.
-
Indications for treatment of Helicobacter pylori infection: a systematic overview.CMAJ. 1994 Jan 15;150(2):189-98. CMAJ. 1994. PMID: 8287341 Free PMC article. Review.
-
Patient-based assessment in dyspepsia: development and validation of Dyspepsia Symptom Severity Index (DSSI).Dig Dis Sci. 2000 Jun;45(6):1172-9. doi: 10.1023/a:1005558204440. Dig Dis Sci. 2000. PMID: 10877234
-
Functional dyspepsia. Current treatment recommendations.Drugs. 1993 Jun;45(6):918-930. doi: 10.2165/00003495-199345060-00005. Drugs. 1993. PMID: 7691499 Review.
-
Antacid (A02A) and antiulcer (A02B) drug prescription patterns: predicting factors, dosage and treatment duration.Eur J Epidemiol. 1998 Jun;14(4):363-72. doi: 10.1023/a:1007493003891. Eur J Epidemiol. 1998. PMID: 9690755
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical